Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,305 USD | +5,25% | +6,38% | -29,70% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Willard
CEO | Chief Executive Officer | 63 | 12-07-22 |
Jonathan Javitt
FOU | Founder | 67 | 18-09-17 |
Richard Narido
DFI | Director of Finance/CFO | 46 | 13-09-23 |
Chief Tech/Sci/R&D Officer | - | 05-12-22 | |
Rick Panicucci
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Corporate Officer/Principal | - | 01-10-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Javitt
FOU | Founder | 67 | 18-09-17 |
Stephen Willard
CEO | Chief Executive Officer | 63 | 12-07-22 |
Janet Rehnquist
BRD | Director/Board Member | - | 27/12 |
Patrick J. Flynn
BRD | Director/Board Member | 75 | 24-05-21 |
Chaim Hurvitz
BRD | Director/Board Member | 63 | 24-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 488 067 | 7 612 875 ( 72,59 %) | 0 | 72,59 % |
Aandeel B | 0 | 3 000 000 | 0 | 0 |
Bedrijfsgegevens
Sector
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-29,70% | 32,72 mln. | |
+1,48% | 42,59 mld. | |
+7,92% | 40,65 mld. | |
+48,66% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+7,94% | 24,81 mld. | |
-24,76% | 18,17 mld. | |
+29,12% | 12,05 mld. | |
-2,70% | 11,7 mld. | |
+7,23% | 11,1 mld. |
- Beurs
- Aandelen
- Koers BRPA
- Onderneming NRx Pharmaceuticals, Inc.